OrderlyMeds’ Response to Eli Lilly’s Cease-and-Desist Letter
Hand-out
Press Releases
OrderlyMeds  
April 11, 2025

OrderlyMeds’ Response to Eli Lilly’s Cease-and-Desist Letter

ATLANTA, April 11, 2025 /PRNewswire/ -- On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response.

avatar profile Olean Times Herald

Olean Times Herald


Local & Social